Fierce Biotech Next Gen 2023

Max Bayer is a staff writer for Fierce Biotech. He joined after more than three years at CBS News, two of which were spent covering the twists and turns of the COVID-19 pandemic, from infection trends to CDC guidelines. He graduated from the University of Wisconsin-Madison in 2018... Read More →

Antoine Papiernik is Chairman and Managing Partner at Sofinnova Partners, which he joined in 1997. He has been an initial investor and active board member in a number of public companies, including Actelion, ProQR, Shockwave Medical, NovusPharma (sold to CTI), and Movetis (sold... Read More →